Table 4.
Mean (and the lower and upper quartile) MDA, TOS, TAS and OSI serum concentrations in both groups.
| Clinical Feature | MDA [ng/mL] | p | TOS [µmol/L] | p | TAS [µmol/L] | p | OSI | p |
|---|---|---|---|---|---|---|---|---|
| Women (n = 42) | 2825.38 (1107.77–3679.28) |
0.906 | 865.86 (550.71–1172.70) |
0.312 | 271.23 (231.59–318.27) |
0.684 | 333.13 (218.47–461.86) |
0.316 |
| Men (n = 52) | 2511.15 (1363.10–3332.79) |
779.76 (463.87–1114.00) |
271.65 (234.06–291.02) |
298.92 (176.94–412.92) |
||||
| Normal weight (n = 44) |
2539.27 (849.06–3270.09) |
0.222 | 824.73 (483.44–1224.07) |
0.718 | 279.49 (240.07–309.13) |
0.329 | 313.29 (194.32–456.19) |
0.513 |
| Overweight (n = 30) |
2469.70 (1159.57–3332.79) |
762.91 (550.71–925.30) |
262.43 (223.31–294.23) |
297.35 (228.10–409.07) |
||||
| Obesity (n = 20) | 3171.34 (2052.11–4563.89) |
886.93 (487.93–1196.42) |
267.35 (234.00–275.47) |
341.51 (202.75–467.98) |
||||
| CSI, CSII (n = 26) | 2363.53 (1067.92–3207.38) |
0.087 | 772.09 (454.27–1088.14) |
0.794 | 275.27 (223.31–324.42) |
0.741 | 295.03 (159.27–429.00) |
0.970 |
| CSIII (n = 29) | 2184.48 (1247.52–2922.36) |
877.48 (531.84–1185.98) |
263.38 (233.33–272.46) |
342.40 (218.47–413.69) |
||||
| CSIV (n = 39) | 3190.87 (1645.42–4259.26) |
804.94 (464.29–1158.03) |
274.93 (232.53–291.55) |
306.02 (185.54–450.52) |
||||
| All CRC patients (n = 94) |
2651.55 (1159.57–3332.79) |
- | 818.23 (510.17–1158.03) |
- | 271.46 (232.56–293.44) |
- | 314.20 (203.09–429.00) |
- |
| Left-sided colon (n = 32) |
2329.20 (1314.10–3270.09) |
0.035 | 812.66 (468.88–1114.00) |
0.910 | 273.49 (232.79–292.36) |
0.637 | 314.08 (202.75–445.43) |
0.586 |
| Right-sided colon (n = 21) |
3565.06 (2186.88–4259.26) |
810.12 (590.26–925.30) |
269.97 (226.35–318.27) |
308.09 (233.25–409.07) |
||||
| Rectum (n = 30) |
2551.27 (1067.92–3269.21) |
793.26 (452.77–1185.98) |
274.23 (243.35–278.47) |
301.33 (165.51–450.52) |
||||
| All CRC patients (n = 83) |
2722.15 (1311.65–3398.18) |
- | 805.00 (493.40–1130.07) |
- | 272.87 (232.53–294.23) |
- | 307.95 (203.09–429.00) |
- |
| Control group (n = 26) |
6459.85 (2751.18–9743.30) |
- | 470.63 (111.75–838.83) |
- | 320.65 (285.90–389.55) |
- | 164.84(28.14–290.25) | - |